J Gynecol Oncol.  2012 Apr;23(2):133-133. 10.3802/jgo.2012.23.2.133A.

HE4, CA-125, and cystic ovarian mass

• Wiwanitkit V

• KMID: 2177589
• DOI: http://doi.org/10.3802/jgo.2012.23.2.133A

Abstract

No abstract available.

Reference

1. Partheen K, Kristjansdottir B, Sundfeldt K. Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass. J Gynecol Oncol. 2011. 22:244–252.

2. Molina R, Escudero JM, Auge JM, Filella X, Foj L, Torne A, et al. HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases. Tumour Biol. 2011. 32:1087–1095.

3. Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Drescher CW, et al. Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer. Gynecol Oncol. 2010. 116:378–383.